Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Clintrial Medical Center S.R.L.

Research site

Romania Str Romulus Nr 1, Sat Resca, 237143 Dobrosloveni, Romania

  • Atrial fibrillation
  • Adult patients

About Specializations

Clintrial Medical Center S.R.L. in Dobrosloveni, Romania specialises in clinical trials of conditions such as Atrial fibrillation, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiology – Atrial Fibrillation Research

The Cardiology department at Clintrial Medical Center S.R.L. focuses on atrial fibrillation, seeking to lower the risk of stroke and systemic embolism while closely monitoring bleeding outcomes in patients.

  • Evaluation of new anticoagulant therapies
  • Comparison with established agents such as apixaban
  • Assessment of major and clinically relevant bleeding

The work supports the advancement of safer and more effective anticoagulation options for individuals unsuitable for conventional oral treatment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Str Romulus Nr 1, Sat Resca237143 DobrosloveniRomania
Open in maps ↗
Recruiting now
no trials
Conditions studied
1

More sites in DobrosloveniRomania

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Atrial fibrillation

Not yet recruiting

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:REGN7508
  • Sponsor:Regeneron Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.